Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Other Accumulated Expenses (2022 - 2024)

Adial Pharmaceuticals' Other Accumulated Expenses history spans 3 years, with the latest figure at $5816.0 for Q3 2024.

  • For Q3 2024, Other Accumulated Expenses fell 99.28% year-over-year to $5816.0; the TTM value through Sep 2024 reached $5816.0, down 99.28%, while the annual FY2023 figure was $47942.0, 361.56% up from the prior year.
  • Other Accumulated Expenses for Q3 2024 was $5816.0 at Adial Pharmaceuticals, roughly flat from $5816.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $813371.0 in Q3 2023 and bottomed at $3638.0 in Q1 2023.
  • The 3-year median for Other Accumulated Expenses is $9859.0 (2022), against an average of $101897.2.
  • The largest annual shift saw Other Accumulated Expenses surged 9599.15% in 2023 before it crashed 99.28% in 2024.
  • A 3-year view of Other Accumulated Expenses shows it stood at $10387.0 in 2022, then soared by 361.56% to $47942.0 in 2023, then plummeted by 87.87% to $5816.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Other Accumulated Expenses are $5816.0 (Q3 2024), $5816.0 (Q2 2024), and $47942.0 (Q4 2023).